📰 New Liver Meds Take New Approaches
MedEvidence! Truth Behind the Data
More Info
MedEvidence! Truth Behind the Data
📰 New Liver Meds Take New Approaches
Jul 07, 2023
Dr. Michael Koren

Send us a Text Message.

Who knew the liver could be so fascinating? Ready to take a deep dive into non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)? Brace yourselves as we unravel the enigma that is your liver, spotlighting how everyday lifestyle choices and medical conditions such as diabetes and obesity can lead to these surprisingly common, yet largely untreatable liver ailments. We'll also dissect the impact of genetics and diet, leaving no stone unturned in our lively discussion.

This week's episode brings you groundbreaking research and innovative medical strategies aimed at tackling NAFLD and NASH. We delve into the science of managing fat, sugar, and inflammation in the liver, and explore how hormones like thyroid receptor beta and Fibroblast Growth Factor 21 can play a part in long-term solutions. Also, we shed light on the role of gene mutations in liver health and the promising new medications being developed to target these issues specifically. With discussions full of insights and revelations, this is one conversation you won't want to miss!

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!